I
n the abstract of their study, Wang and colleagues write, "Acromioclavicular joint arthritis is a common, painful, and often missed diagnosis, and it often accompanies other shoulder conditions such as rotator cuff disease" [13] .
Acromioclavicular joint changes seen on an MRI and rotator cuff disease both are consequences of aging.
MRIs are usually a part of the workup of patients suspected of having cuff tendon problems, therefore radiologists will often "diagnose" acromioclavicular joint arthritis in their reading of these images, without knowing if the commonly noted AC joint MRI changes are symptomatic or just incidental findings. Because both conditions increase in frequency as we age, it is no surprise that there is a "strong association between rotator cuff tears and acromioclavicular joint degenerative arthritis" [13] . But this association does not imply causation [3] . Symptomatic acromioclavicular joint arthritis is a relatively easy diagnosis to make clinically, presenting as pain localized at the lateral end of the clavicle that is exacerbated with cross-body adduction or with active contraction of the pectoralis major (as with a push up or bench press). Treatment includes nonsteroidal antiinflammatory medications and activity modification. Resistant symptoms can be managed with a carefully performed distal clavicle excision followed by stabilizing soft-tissue reconstruction. As Wang and colleagues [13] note, acromioclavicular joint instability can complicate distal clavicle resection. There are surgeons who combine distal clavicle excision with rotator cuff repair, perhaps out of concern for the effect of acromioclavicular joint changes on the cuff, or out of belief that such surgery may be preventative, or just "because it's there" [9] .
Wang and colleagues [13] ask whether there is evidence that patients receive added benefit when a distal clavicle excision is added to rotator cuff surgery. They found no evidence that distal clavicle resection in patients with rotator cuff tears resulted in better clinical outcome scores or shoulder ROM, or that it was associated with a lower risk of reoperation.
Where Do We Need To Go?
The current study provides perspective on the tendency for some surgeons to perform extra procedures "while we are in there." We see this tendency when a surgeon combines tenodesis of a healthy biceps with shoulder arthroplasty [12] or when acromioplasty is combined with rotator cuff repair [6] . In these instances, the extra procedure is not directed at the primary pathology; therefore, the potential benefits and risks to the patient need to be carefully assessed. Sometimes, as in the current study, the extra procedure carries complications not associated with the treatment of the primary problem.
Thus, there is an opportunity for researchers to investigate both the incremental benefit of extra procedures to the patient as well as the related increased costs in both dollars and complications. Future studies should also determine whether these extra procedures result in added Current Procedural Terminology (CPT) codes and increased surgical fees. In essence, we need to know if there is clinical evidence of incremental value (increased benefit divided by increased cost) for each extra procedure.
Although rotator cuff surgery is the most-common shoulder procedure performed in the United States, neither the American Academy of Orthopaedic Surgeons Clinical Practice Guidelines [10] nor the Cochrane Collaboration [2] provide clinically useful guidance for managing rotator cuff disease, and neither provide any commentary regarding the value of combining distal clavicle excision with rotator cuff surgery.
Each year, advocates promote new approaches to cuff disease, including platelet-rich plasma, stem cells, scaffolds, patches, superior capsular reconstruction [7] , and subacromial balloon spacers [11] without evidence that the increased cost is offset by commensurate increased benefit to the patient in comparison to less expensive approaches [4] .
How can we sort this out? One would think that with upwards of 500,000 rotator cuff surgeries per year [5] , we have plenty of patients; the problem is that individuals with rotator cuff disease will be improved by just about any treatment, ranging from physical therapy and injection to a whole host of surgical procedures. And beyond that, one important question remains unanswered: Do extra procedures provide additional benefits? The most robust way to answer this question would be to prospectively randomize patients to "standard treatment" versus "standard treatment + extra procedure" groups. If 50 patients (1/10,000th of the rotator cuff surgeries performed each year) were included in each study, we would have some solid evidence for determining the value of the extra procedure.
We may lack the collective motivation to conduct such studies-each would take plenty of work, and the results may not please the advocates of the extra procedures.
How Do We Get There?
The difference in relative value units (RVUs) and physician charges for a cuff repair surgery are increased by the performance of extra procedures. The RVU for rotator cuff repair alone is 15.6 RVU, whereas the total RVUs for cuff repair plus distal clavicle resection plus biceps tenodesis plus extensive débridement would be almost three times more if billed separately (15.6 + 9 + 13 + 8.4 = 46) [1] . Using national databases, researchers could determine the rate and economic effect of extra procedures associated with cuff repair. For the ICD code for rotator cuff disease, what is the frequency distribution of CPT codes for extra procedures done in association with the surgical treatment of this diagnoses? In addition, what is the effect of these extra procedures on the surgeon and facility charges?
In exploring the use and costeffectiveness of extra procedures, we can recall the observation of E.A. Codman: "It is the duty of no one and it is for the interest of no one-except for the patients and for the community" [8] . Can we rise (at least a bit) to the challenge?
